Michael Egholm's Net Worth
$4.24 Million
Who is Michael Egholm?
Michael Egholm has an estimated net worth of $4.24 Million. This is based on reported shares across multiple companies, which include STANDARD BIOTOOLS INC., IsoPlexis Corp, and PALL CORP.
SEC CIK
Michael Egholm's CIK is 0001559779
Past Insider Trading and Trends
2013 was Michael Egholm's most active year for acquiring shares with 11 total transactions. Michael Egholm's most active month to acquire stocks was the month of December. 2015 was Michael Egholm's most active year for disposing of shares, totalling 17 transactions. Michael Egholm's most active month to dispose stocks was the month of June. 2015 saw Michael Egholm paying a total of $3,892,883.83 for 37,811.097 shares, this is the most they've acquired in one year. In 2015 Michael Egholm cashed out on 116,006.874 shares for a total of $6,771,643.21, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
STANDARD BIOTOOLS INC. (LAB) Snapshot price: $2.33
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +188.11% | 1M |
—
|
—
| 1.53M |
May 20
| |||
Form 4
| -16.17% | -102.56K |
$2.71 | -$277,948.44 | 531.59K |
Apr 8
| |||
Form 4
| +192.90% | 417.64K |
—
|
—
| 634.16K |
Jan 5 - Apr 5
| |||
Form 4
| +1,965.12% | 196.51K |
—
|
—
| 206.51K |
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IsoPlexis Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PALL CORP No price found
President, BioPharmaceuticals
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -41.42K |
$127.20 | -$3,637,973.55 |
0
|
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 19
| |||
Form 4
| +885.12% | 8.27K |
$126.67 | $1,047,180.89 | 9.2K |
Aug 13
| |||
Form 4
| +140,562.20% | 933.33 |
$125.52 | $117,151.96 | 934 |
Jul 13 - Jul 15
| |||
Form 4
|
—
|
0
|
$97.12 | -$852,471.73 | 0.66 |
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| -99.95% | -1.47K |
$79.64 | -$401,354.82 | 0.66 |
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
| +444,645.76% | 1.47K |
$71.43 | $16,036.96 | 1.47K |
Jul 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
| -99.99% | -2.94K |
$67.81 | -$199,504.09 | 0.33 |
Mar 7
| |||
Form 4
|
∞
| 2.94K |
$68.51 | $201,579.23 | 2.94K |
Jan 31 - Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
—
|
0
|
$50.43 | -$53,069.20 |
0
|
Jan 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||